B-Cells and BAFF in Primary Antiphospholipid Syndrome, Targets for Therapy?

B-Cells and BAFF in Primary Antiphospholipid Syndrome, Targets for Therapy?

Primary antiphospholipid syndrome (PAPS) is a systemic autoimmune disease characterized by thrombosis, pregnancy morbidity, and the presence of antiphospholipid antibodies (aPL). Anticoagulants form the mainstay of treatment in PAPS. A growing number of studies suggest a previously underappreciated...

Full description

Bibliographic Details
Main Authors: Lucas L. van den Hoogen, Radjesh J. Bisoendial
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Journal of Clinical Medicine
Subjects:
antiphospholipid syndrome
B-cell
plasmablast
BAFF
BLyS
rituximab
Online Access:https://www.mdpi.com/2077-0383/12/1/18

Internet

https://www.mdpi.com/2077-0383/12/1/18

Similar Items